Evidence map›Paper›PMID 16505652›Full record

Trial reportCritical care medicine2006

Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine.

Tsutomu Sakuma, Xiu Gu, Zheng Wang, Sumiko Maeda, Makoto Sugita, Motoyasu Sagawa, Kazuhiro Osanai, Hirohisa Toga, Lorraine B Ware, G Folkesson and 1 more

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Critical care medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Acquired cystic fibrosis transmembrane conductance regulator dysfunction.Pflugers Archiv : European journal of physiology · 2025
    Review
  4. Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Article
  5. Review
  6. Review
  7. Bioengineering approaches to organ preservation ex vivo.Experimental biology and medicine (Maywood, N.J.) · 2019
    Review
  8. Article
  9. Review
  10. The role of ex vivo lung perfusion in lung transplantation.Journal of the Intensive Care Society · 2015
    Article
  11. Article
  12. The Fas/FasL pathway impairs the alveolar fluid clearance in mouse lungs.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  13. IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Alveolar edema fluid clearance and acute lung injury.Respiratory physiology & neurobiology · 2007
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Tsutomu SakumaThoracic Surgery, Kanazawa Medical University, Uchinada, Ishikawa, Japan. sakuma-t@kanazawa-med.ac.jp
Xiu Gu
Zheng Wang
Sumiko Maeda
Makoto Sugita
Motoyasu Sagawa
Kazuhiro Osanai
Hirohisa Toga
Lorraine B Ware
G Folkesson
Michael A Matthay
Kanazawa Medical University · JP

Funding

Resolution of Clinical Lung InjuryR37HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2006 to 2015
$3.9M
RESOLUTION OF CLINICAL LUNG INJURYR01HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 1996 to 2005
$1.7M
Alveolar Epithelium in Acute Lung InjuryK08HL070521 · NHLBI · VANDERBILT UNIVERSITY · PI WARE, LORRAINE B · 2001 to 2005
$609k
SYNTHETIC VEHICLES FOR TARGETED GENE DELIVERY FOR CYSTIC FIBROSISP01HL051754 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 1993 to 1997
–
NHLBI NIH HHS HL51754NHLBI NIH HHS HL51856NHLBI NIH HHS HL 70521NHLBI NIH HHS K08 HL070521NHLBI NIH HHS R01 HL051856NHLBI NIH HHS R37 HL051856
6 · The paper itself

Abstract

objectivesBecause several experimental studies have demonstrated that cyclic adenosine monophosphate generation following beta-adrenoceptor activation can markedly stimulate alveolar fluid clearance, we determined whether the endogenous levels of catecholamines that occur in the pulmonary edema fluid and plasma of patients with acute lung injury are high enough to stimulate alveolar fluid clearance in the human lung.

designObservational clinical study.

settingAcademic university hospital and laboratory. PATIENTS: Twenty-one patients with acute pulmonary edema plus ex vivo human lungs.

interventionsMeasurements of catecholamine levels in patient samples and controlled laboratory studies of the effects of these catecholamine levels on the rates of alveolar fluid clearance in ex vivo human lungs. MEASUREMENTS AND MAIN

resultsThe concentrations of both epinephrine and norepinephrine in the pulmonary edema fluid and plasma were approximately 10 M (range of 1-8x10 M) in hydrostatic pulmonary edema (n=6) and acute lung injury patients (n=15). We therefore tested whether 10 M epinephrine or norepinephrine stimulated alveolar fluid clearance in isolated human lungs and found that these epinephrine or norepinephrine concentrations did not stimulate alveolar fluid clearance. However, higher concentrations of epinephrine (10 M), but not norepinephrine (10 M), significantly stimulated alveolar fluid clearance by 84% above control. Glibenclamide (10 M) and CFTRinh-172 (10 M), cystic fibrosis transmembrane conductance regulator inhibitors, completely inhibited the epinephrine-induced stimulation of alveolar fluid clearance.

conclusionsThese results indicate that endogenous catecholamine concentrations in pulmonary edema fluid are probably not sufficient to stimulate alveolar fluid clearance. In contrast, administration of exogenous catecholamines into the distal airspaces can stimulate alveolar fluid clearance in the human lung, an effect that is mediated in part by cystic fibrosis transmembrane conductance regulator. Therefore, exogenous cyclic adenosine monophosphate-dependent stimulation will probably be required to accelerate the resolution of alveolar edema in the lungs of patients with pulmonary edema.

Indexed as

Adrenergic beta-AgonistsAnalysis of VarianceCatecholaminesCystic Fibrosis Transmembrane Conductance RegulatorEpinephrineFemaleGlyburideHumansMaleMiddle AgedPulmonary AlveoliPulmonary EdemaAdrenergic beta-AgonistsCatecholaminesCystic Fibrosis Transmembrane Conductance RegulatorEpinephrineGlyburide

Identifiers

PMID16505652
PMCPMC2765117
OpenAlexW2005401154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.